Cell-free DNA is fragmented DNA originating from cells and continuously released into the bloodstream.
AlloSure Kidney measures cfDNA, and uses single nucleotide polymorphisms (SNPs) to distinguish between donor and recipient.
AlloSure can quantify increasing levels of dd-cfDNA, serving as a leading indicator of graft injury.
